Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rehabilitation Centers | 6 | 2013 | 69 | 1.360 |
Why?
|
Neoplasms | 19 | 2019 | 15660 | 0.940 |
Why?
|
Helicobacter pylori | 14 | 2013 | 1320 | 0.940 |
Why?
|
Inpatients | 3 | 2013 | 698 | 0.670 |
Why?
|
Meditation | 1 | 2019 | 76 | 0.640 |
Why?
|
Yoga | 1 | 2019 | 86 | 0.630 |
Why?
|
Length of Stay | 8 | 2014 | 2024 | 0.620 |
Why?
|
Subacute Care | 1 | 2017 | 13 | 0.580 |
Why?
|
Rehabilitation | 1 | 2017 | 37 | 0.570 |
Why?
|
Spinal Cord Compression | 2 | 2010 | 159 | 0.530 |
Why?
|
Autonomic Nervous System Diseases | 2 | 2013 | 69 | 0.520 |
Why?
|
Heme Oxygenase (Decyclizing) | 3 | 2010 | 20 | 0.510 |
Why?
|
Heme | 3 | 2012 | 78 | 0.510 |
Why?
|
Peripheral Nervous System Diseases | 3 | 2014 | 389 | 0.510 |
Why?
|
Activities of Daily Living | 3 | 2011 | 540 | 0.490 |
Why?
|
Thioctic Acid | 1 | 2013 | 13 | 0.470 |
Why?
|
Cancer Care Facilities | 6 | 2013 | 904 | 0.460 |
Why?
|
Sacrum | 2 | 2005 | 135 | 0.440 |
Why?
|
Neurotoxicity Syndromes | 1 | 2013 | 119 | 0.420 |
Why?
|
Genome, Bacterial | 2 | 2012 | 201 | 0.410 |
Why?
|
Spinal Neoplasms | 2 | 2010 | 656 | 0.400 |
Why?
|
Heart Rate | 3 | 2013 | 744 | 0.390 |
Why?
|
Asthenia | 1 | 2011 | 18 | 0.390 |
Why?
|
Patient Transfer | 2 | 2012 | 140 | 0.380 |
Why?
|
Hemipelvectomy | 1 | 2011 | 40 | 0.380 |
Why?
|
Relaxation Therapy | 1 | 2010 | 19 | 0.370 |
Why?
|
Recovery of Function | 2 | 2011 | 720 | 0.360 |
Why?
|
Health Planning | 1 | 2010 | 28 | 0.360 |
Why?
|
DNA, Bacterial | 1 | 2012 | 572 | 0.360 |
Why?
|
Resuscitation Orders | 1 | 2010 | 70 | 0.350 |
Why?
|
Advance Directives | 1 | 2010 | 89 | 0.340 |
Why?
|
Hospitalization | 4 | 2013 | 2202 | 0.340 |
Why?
|
Pelvic Neoplasms | 1 | 2011 | 203 | 0.340 |
Why?
|
Intensive Care Units | 3 | 2012 | 746 | 0.330 |
Why?
|
Patient Readmission | 1 | 2013 | 588 | 0.330 |
Why?
|
Arrhythmias, Cardiac | 1 | 2013 | 510 | 0.330 |
Why?
|
Muscle Spasticity | 2 | 2012 | 82 | 0.330 |
Why?
|
Azotemia | 1 | 2007 | 2 | 0.300 |
Why?
|
Hyperglycemia | 1 | 2010 | 338 | 0.300 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2008 | 195 | 0.300 |
Why?
|
Helicobacter Infections | 7 | 2012 | 1243 | 0.300 |
Why?
|
Primary Health Care | 1 | 2013 | 846 | 0.290 |
Why?
|
Adrenal Cortex Hormones | 1 | 2010 | 557 | 0.280 |
Why?
|
Patient Discharge | 3 | 2007 | 707 | 0.280 |
Why?
|
Hip Joint | 2 | 2004 | 56 | 0.280 |
Why?
|
Middle Aged | 29 | 2014 | 89316 | 0.270 |
Why?
|
Lymphoma | 2 | 2013 | 1498 | 0.260 |
Why?
|
Bacterial Proteins | 5 | 2013 | 1048 | 0.260 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 1215 | 0.260 |
Why?
|
Neurosurgical Procedures | 1 | 2010 | 637 | 0.250 |
Why?
|
Aged, 80 and over | 14 | 2014 | 30711 | 0.250 |
Why?
|
Fecal Incontinence | 1 | 2005 | 87 | 0.250 |
Why?
|
Drug Prescriptions | 1 | 2007 | 310 | 0.240 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 2505 | 0.240 |
Why?
|
Urinary Incontinence | 1 | 2005 | 146 | 0.240 |
Why?
|
Aged | 22 | 2014 | 72676 | 0.240 |
Why?
|
Neuromuscular Agents | 2 | 2012 | 86 | 0.240 |
Why?
|
Nutritional Support | 1 | 2004 | 79 | 0.240 |
Why?
|
Adult | 23 | 2013 | 80554 | 0.230 |
Why?
|
Hip Contracture | 1 | 2003 | 2 | 0.230 |
Why?
|
Prone Position | 1 | 2003 | 59 | 0.220 |
Why?
|
Male | 30 | 2014 | 127252 | 0.220 |
Why?
|
Transportation of Patients | 1 | 2003 | 59 | 0.220 |
Why?
|
Radial Nerve | 1 | 2002 | 4 | 0.210 |
Why?
|
Trauma, Nervous System | 1 | 2002 | 11 | 0.210 |
Why?
|
Clothing | 1 | 2002 | 21 | 0.200 |
Why?
|
Botulinum Toxins | 1 | 2004 | 136 | 0.200 |
Why?
|
Immobilization | 1 | 2002 | 95 | 0.200 |
Why?
|
Female | 33 | 2014 | 146867 | 0.200 |
Why?
|
Vulvar Neoplasms | 1 | 2004 | 235 | 0.200 |
Why?
|
Hemin | 3 | 2010 | 24 | 0.200 |
Why?
|
Ossification, Heterotopic | 1 | 2002 | 72 | 0.200 |
Why?
|
Malnutrition | 1 | 2004 | 224 | 0.200 |
Why?
|
Humans | 40 | 2019 | 270139 | 0.200 |
Why?
|
Molecular Sequence Data | 7 | 2013 | 6120 | 0.180 |
Why?
|
Wounds, Gunshot | 1 | 2002 | 108 | 0.180 |
Why?
|
Postoperative Complications | 3 | 2011 | 5807 | 0.180 |
Why?
|
Wounds, Nonpenetrating | 1 | 2002 | 179 | 0.180 |
Why?
|
Wound Healing | 1 | 2005 | 813 | 0.180 |
Why?
|
Chordoma | 1 | 2002 | 168 | 0.180 |
Why?
|
Interleukin-17 | 3 | 2010 | 262 | 0.170 |
Why?
|
Quality of Life | 1 | 2013 | 4713 | 0.170 |
Why?
|
Pain Measurement | 4 | 2014 | 988 | 0.170 |
Why?
|
Iron | 3 | 2012 | 378 | 0.160 |
Why?
|
Retrospective Studies | 14 | 2014 | 39420 | 0.160 |
Why?
|
Creatinine | 3 | 2012 | 552 | 0.150 |
Why?
|
Social Work | 1 | 2007 | 26 | 0.150 |
Why?
|
Gastric Mucosa | 2 | 2012 | 621 | 0.140 |
Why?
|
Rectal Neoplasms | 1 | 2005 | 1237 | 0.140 |
Why?
|
Parkinson Disease | 1 | 2004 | 703 | 0.140 |
Why?
|
Young Adult | 8 | 2013 | 22095 | 0.140 |
Why?
|
Recombinant Fusion Proteins | 2 | 2013 | 1593 | 0.140 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 1354 | 0.140 |
Why?
|
Comorbidity | 2 | 2017 | 2454 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 10257 | 0.130 |
Why?
|
Incidence | 3 | 2013 | 5888 | 0.120 |
Why?
|
Paraneoplastic Cerebellar Degeneration | 1 | 2014 | 4 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 16253 | 0.120 |
Why?
|
Electroacupuncture | 1 | 2014 | 33 | 0.120 |
Why?
|
Staphylococcal Vaccines | 1 | 2013 | 3 | 0.120 |
Why?
|
Amino Acid Sequence | 5 | 2013 | 4277 | 0.120 |
Why?
|
Social Support | 1 | 2007 | 581 | 0.120 |
Why?
|
Mice, Inbred BALB C | 7 | 2013 | 2389 | 0.110 |
Why?
|
Heart Function Tests | 1 | 2013 | 73 | 0.110 |
Why?
|
Vaccines, Subunit | 1 | 2013 | 126 | 0.110 |
Why?
|
Phenol | 1 | 2012 | 18 | 0.110 |
Why?
|
Tibet | 1 | 2012 | 11 | 0.110 |
Why?
|
Arginase | 1 | 2013 | 44 | 0.110 |
Why?
|
Placebos | 1 | 2013 | 448 | 0.110 |
Why?
|
Stress, Psychological | 2 | 2010 | 1031 | 0.110 |
Why?
|
Adaptation, Psychological | 1 | 2007 | 790 | 0.100 |
Why?
|
Alkyl and Aryl Transferases | 1 | 2012 | 90 | 0.100 |
Why?
|
Medical Staff, Hospital | 1 | 2013 | 118 | 0.100 |
Why?
|
Administration, Oral | 2 | 2013 | 1583 | 0.100 |
Why?
|
Multiple Myeloma | 3 | 2014 | 2239 | 0.100 |
Why?
|
Minisatellite Repeats | 1 | 2011 | 52 | 0.100 |
Why?
|
Bacterial Adhesion | 1 | 2012 | 146 | 0.100 |
Why?
|
Immunity | 1 | 2013 | 356 | 0.100 |
Why?
|
Treatment Outcome | 8 | 2014 | 34145 | 0.100 |
Why?
|
Organoplatinum Compounds | 1 | 2013 | 706 | 0.090 |
Why?
|
Virulence Factors, Bordetella | 1 | 2010 | 41 | 0.090 |
Why?
|
Bordetella pertussis | 1 | 2010 | 18 | 0.090 |
Why?
|
Pertussis Toxin | 1 | 2010 | 59 | 0.090 |
Why?
|
Comprehensive Health Care | 1 | 2011 | 49 | 0.090 |
Why?
|
Pertussis Vaccine | 1 | 2010 | 28 | 0.090 |
Why?
|
Nerve Block | 1 | 2012 | 179 | 0.090 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 306 | 0.090 |
Why?
|
Plasmids | 1 | 2012 | 843 | 0.090 |
Why?
|
Adhesins, Bacterial | 1 | 2010 | 85 | 0.090 |
Why?
|
Schools, Medical | 1 | 2011 | 136 | 0.090 |
Why?
|
Survival | 1 | 2010 | 177 | 0.090 |
Why?
|
Botulinum Toxins, Type A | 1 | 2012 | 193 | 0.090 |
Why?
|
Uterine Neoplasms | 1 | 2014 | 566 | 0.090 |
Why?
|
Crystallography, X-Ray | 4 | 2013 | 644 | 0.090 |
Why?
|
Pain Management | 2 | 2013 | 696 | 0.090 |
Why?
|
Stomach Diseases | 1 | 2009 | 63 | 0.080 |
Why?
|
Texas | 3 | 2007 | 6450 | 0.080 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2010 | 210 | 0.080 |
Why?
|
RNA, Bacterial | 1 | 2009 | 81 | 0.080 |
Why?
|
Palliative Care | 2 | 2011 | 2126 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2002 | 2652 | 0.080 |
Why?
|
Urease | 1 | 2008 | 62 | 0.080 |
Why?
|
Disability Evaluation | 1 | 2010 | 236 | 0.080 |
Why?
|
Th1 Cells | 1 | 2010 | 259 | 0.080 |
Why?
|
Th17 Cells | 1 | 2010 | 172 | 0.080 |
Why?
|
Bacterial Vaccines | 1 | 2008 | 103 | 0.080 |
Why?
|
Adolescent | 6 | 2011 | 32286 | 0.080 |
Why?
|
Physical Therapy Modalities | 2 | 2014 | 96 | 0.080 |
Why?
|
Stomach Neoplasms | 2 | 2012 | 2336 | 0.080 |
Why?
|
Acupuncture Therapy | 1 | 2009 | 94 | 0.080 |
Why?
|
Intubation, Gastrointestinal | 1 | 2008 | 87 | 0.080 |
Why?
|
Staphylococcal Infections | 1 | 2013 | 675 | 0.080 |
Why?
|
Double-Blind Method | 1 | 2013 | 2655 | 0.080 |
Why?
|
Serum Albumin | 1 | 2008 | 250 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2004 | 5530 | 0.070 |
Why?
|
Appetite Stimulants | 1 | 2007 | 14 | 0.070 |
Why?
|
Blood Urea Nitrogen | 1 | 2007 | 97 | 0.070 |
Why?
|
Prealbumin | 1 | 2007 | 37 | 0.070 |
Why?
|
Astrocytoma | 1 | 2010 | 328 | 0.070 |
Why?
|
Cathartics | 1 | 2007 | 43 | 0.070 |
Why?
|
Appetite | 1 | 2007 | 70 | 0.070 |
Why?
|
Risk Factors | 3 | 2010 | 18227 | 0.070 |
Why?
|
Dehydration | 1 | 2007 | 89 | 0.070 |
Why?
|
Bone Marrow Transplantation | 1 | 2012 | 1619 | 0.070 |
Why?
|
Electrocardiography | 1 | 2013 | 1218 | 0.070 |
Why?
|
RNA, Untranslated | 1 | 2009 | 244 | 0.070 |
Why?
|
Sequence Alignment | 1 | 2008 | 846 | 0.070 |
Why?
|
T-Lymphocyte Subsets | 1 | 2010 | 592 | 0.070 |
Why?
|
Genetic Variation | 2 | 2012 | 2112 | 0.070 |
Why?
|
Stomach | 1 | 2009 | 391 | 0.070 |
Why?
|
Gene Transfer Techniques | 1 | 2009 | 728 | 0.070 |
Why?
|
Education, Medical | 1 | 2011 | 359 | 0.070 |
Why?
|
Cisplatin | 1 | 2013 | 2454 | 0.070 |
Why?
|
Constipation | 1 | 2007 | 180 | 0.070 |
Why?
|
Epitopes | 1 | 2008 | 695 | 0.070 |
Why?
|
China | 3 | 2013 | 626 | 0.070 |
Why?
|
United States | 3 | 2013 | 16318 | 0.070 |
Why?
|
Catheterization | 1 | 2008 | 432 | 0.070 |
Why?
|
Lumbosacral Plexus | 1 | 2005 | 12 | 0.070 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2007 | 134 | 0.060 |
Why?
|
Hypnotics and Sedatives | 1 | 2007 | 222 | 0.060 |
Why?
|
Spinal Nerve Roots | 1 | 2005 | 66 | 0.060 |
Why?
|
Cohort Studies | 2 | 2011 | 9470 | 0.060 |
Why?
|
Colostomy | 1 | 2005 | 79 | 0.060 |
Why?
|
Diabetes Complications | 1 | 2007 | 318 | 0.060 |
Why?
|
Hemoglobins | 1 | 2007 | 482 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 995 | 0.060 |
Why?
|
G2 Phase | 1 | 2005 | 213 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2013 | 15187 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 1278 | 0.060 |
Why?
|
Movement | 2 | 2010 | 556 | 0.060 |
Why?
|
Antidepressive Agents | 1 | 2007 | 341 | 0.060 |
Why?
|
Adenoviridae | 1 | 2009 | 1461 | 0.060 |
Why?
|
Analgesics | 1 | 2007 | 400 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2010 | 806 | 0.060 |
Why?
|
Nutritional Requirements | 1 | 2004 | 187 | 0.060 |
Why?
|
Gene Deletion | 1 | 2008 | 1471 | 0.060 |
Why?
|
Pilot Projects | 1 | 2010 | 2838 | 0.060 |
Why?
|
Walking | 1 | 2005 | 219 | 0.060 |
Why?
|
Hip | 1 | 2003 | 29 | 0.060 |
Why?
|
Macrophages | 1 | 2010 | 1369 | 0.060 |
Why?
|
Communication | 1 | 2010 | 910 | 0.060 |
Why?
|
Injections, Intramuscular | 1 | 2004 | 258 | 0.060 |
Why?
|
Postoperative Period | 1 | 2005 | 672 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2008 | 2941 | 0.050 |
Why?
|
Probability | 1 | 2004 | 889 | 0.050 |
Why?
|
Vecuronium Bromide | 1 | 2002 | 2 | 0.050 |
Why?
|
Carcinoma | 1 | 2014 | 2601 | 0.050 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2002 | 14 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2004 | 4464 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2008 | 1346 | 0.050 |
Why?
|
Pain | 2 | 2009 | 1687 | 0.050 |
Why?
|
Computational Biology | 1 | 2009 | 1299 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 5027 | 0.050 |
Why?
|
Hospital Mortality | 1 | 2008 | 1404 | 0.050 |
Why?
|
Genetic Therapy | 1 | 2009 | 1632 | 0.050 |
Why?
|
Range of Motion, Articular | 1 | 2002 | 140 | 0.050 |
Why?
|
Bacterial Typing Techniques | 2 | 2012 | 141 | 0.050 |
Why?
|
Electrophysiology | 1 | 2002 | 348 | 0.050 |
Why?
|
Fatigue | 1 | 2007 | 1266 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2008 | 4384 | 0.050 |
Why?
|
Age Factors | 1 | 2010 | 5490 | 0.050 |
Why?
|
Survival Rate | 2 | 2004 | 12436 | 0.050 |
Why?
|
Conserved Sequence | 2 | 2012 | 468 | 0.040 |
Why?
|
Cloning, Molecular | 2 | 2013 | 1225 | 0.040 |
Why?
|
Boronic Acids | 2 | 2014 | 364 | 0.040 |
Why?
|
Bortezomib | 2 | 2014 | 549 | 0.040 |
Why?
|
Anxiety | 1 | 2007 | 1240 | 0.040 |
Why?
|
Child | 4 | 2011 | 30137 | 0.040 |
Why?
|
Cytarabine | 1 | 2005 | 1994 | 0.040 |
Why?
|
Pyrazines | 2 | 2014 | 508 | 0.040 |
Why?
|
Surgical Flaps | 1 | 2005 | 959 | 0.040 |
Why?
|
Thalidomide | 2 | 2014 | 577 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2014 | 4728 | 0.040 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2003 | 620 | 0.040 |
Why?
|
Radiography | 1 | 2002 | 1938 | 0.040 |
Why?
|
Hypertension | 1 | 2007 | 1583 | 0.040 |
Why?
|
Mice | 7 | 2013 | 35257 | 0.040 |
Why?
|
Animals | 9 | 2013 | 60893 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2010 | 1502 | 0.040 |
Why?
|
Models, Molecular | 2 | 2013 | 1768 | 0.030 |
Why?
|
Interferon-gamma | 2 | 2010 | 1162 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 1506 | 0.030 |
Why?
|
Speech Therapy | 1 | 2014 | 13 | 0.030 |
Why?
|
Counseling | 1 | 2007 | 386 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 4850 | 0.030 |
Why?
|
Opsonin Proteins | 1 | 2013 | 16 | 0.030 |
Why?
|
Occupational Therapy | 1 | 2014 | 47 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2005 | 1939 | 0.030 |
Why?
|
Blotting, Western | 2 | 2010 | 3596 | 0.030 |
Why?
|
Genotype | 2 | 2012 | 4168 | 0.030 |
Why?
|
Hospitals, County | 1 | 2013 | 29 | 0.030 |
Why?
|
Cations, Divalent | 1 | 2013 | 27 | 0.030 |
Why?
|
Hemiterpenes | 1 | 2012 | 6 | 0.030 |
Why?
|
Polyisoprenyl Phosphates | 1 | 2012 | 4 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2003 | 5234 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 2013 | 94 | 0.030 |
Why?
|
Hospital Units | 1 | 2012 | 38 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2010 | 4992 | 0.030 |
Why?
|
Antibody Formation | 1 | 2013 | 390 | 0.030 |
Why?
|
Hydrogen Bonding | 1 | 2012 | 132 | 0.030 |
Why?
|
Magnesium | 1 | 2013 | 163 | 0.030 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 86 | 0.030 |
Why?
|
Random Amplified Polymorphic DNA Technique | 1 | 2012 | 9 | 0.030 |
Why?
|
Sesquiterpenes | 1 | 2012 | 71 | 0.030 |
Why?
|
Phagocytosis | 1 | 2013 | 274 | 0.030 |
Why?
|
Colony Count, Microbial | 1 | 2012 | 150 | 0.030 |
Why?
|
Organophosphorus Compounds | 1 | 2012 | 104 | 0.030 |
Why?
|
Chemokines | 1 | 2013 | 318 | 0.030 |
Why?
|
Multilocus Sequence Typing | 1 | 2012 | 58 | 0.030 |
Why?
|
Injections | 1 | 2012 | 288 | 0.030 |
Why?
|
Immunization | 1 | 2013 | 402 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2012 | 338 | 0.030 |
Why?
|
Stomach Ulcer | 1 | 2012 | 93 | 0.020 |
Why?
|
Risk Assessment | 1 | 2004 | 7148 | 0.020 |
Why?
|
Molecular Docking Simulation | 1 | 2012 | 167 | 0.020 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2012 | 126 | 0.020 |
Why?
|
Duodenal Ulcer | 1 | 2012 | 116 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 11806 | 0.020 |
Why?
|
Antigens, Bacterial | 1 | 2013 | 369 | 0.020 |
Why?
|
Platelet Count | 1 | 2012 | 494 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2010 | 5664 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2012 | 307 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2012 | 278 | 0.020 |
Why?
|
Spleen | 1 | 2013 | 692 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2012 | 620 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2007 | 933 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2012 | 283 | 0.020 |
Why?
|
Japan | 1 | 2011 | 231 | 0.020 |
Why?
|
Protein Refolding | 1 | 2010 | 2 | 0.020 |
Why?
|
Azides | 1 | 2010 | 32 | 0.020 |
Why?
|
Th1-Th2 Balance | 1 | 2010 | 12 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2012 | 649 | 0.020 |
Why?
|
Interleukin-23 | 1 | 2010 | 30 | 0.020 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2010 | 42 | 0.020 |
Why?
|
Leukocytosis | 1 | 2010 | 114 | 0.020 |
Why?
|
Dimerization | 1 | 2010 | 310 | 0.020 |
Why?
|
Parasympathetic Nervous System | 1 | 2010 | 27 | 0.020 |
Why?
|
Time Factors | 2 | 2014 | 13253 | 0.020 |
Why?
|
Death | 1 | 2011 | 119 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 16030 | 0.020 |
Why?
|
Lac Operon | 1 | 2009 | 124 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2013 | 1062 | 0.020 |
Why?
|
beta-Galactosidase | 1 | 2009 | 221 | 0.020 |
Why?
|
Surveys and Questionnaires | 2 | 2013 | 5916 | 0.020 |
Why?
|
Mifepristone | 1 | 2009 | 153 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2013 | 568 | 0.020 |
Why?
|
Crystallization | 1 | 2009 | 136 | 0.020 |
Why?
|
Rabbits | 1 | 2010 | 978 | 0.020 |
Why?
|
Mutagenesis | 1 | 2010 | 482 | 0.020 |
Why?
|
T-Box Domain Proteins | 1 | 2010 | 163 | 0.020 |
Why?
|
Phylogeny | 1 | 2011 | 843 | 0.020 |
Why?
|
Sympathetic Nervous System | 1 | 2010 | 162 | 0.020 |
Why?
|
Peptic Ulcer | 1 | 2009 | 144 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2009 | 14499 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2009 | 302 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2013 | 7395 | 0.020 |
Why?
|
Interleukin-12 | 1 | 2010 | 265 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2008 | 171 | 0.020 |
Why?
|
Receptors, Glucocorticoid | 1 | 2009 | 195 | 0.020 |
Why?
|
Binding Sites | 1 | 2013 | 2208 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2010 | 386 | 0.020 |
Why?
|
Antibodies, Blocking | 1 | 2008 | 91 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2014 | 2352 | 0.020 |
Why?
|
Gastritis | 1 | 2012 | 378 | 0.020 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2012 | 1232 | 0.020 |
Why?
|
Neutralization Tests | 1 | 2008 | 307 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 571 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2009 | 284 | 0.020 |
Why?
|
Transgenes | 1 | 2009 | 567 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 509 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2009 | 327 | 0.020 |
Why?
|
Antifungal Agents | 1 | 2012 | 854 | 0.020 |
Why?
|
Signal Transduction | 3 | 2010 | 12138 | 0.020 |
Why?
|
Postoperative Care | 1 | 2010 | 751 | 0.020 |
Why?
|
Protein Binding | 1 | 2012 | 3480 | 0.020 |
Why?
|
Students, Medical | 1 | 2011 | 428 | 0.020 |
Why?
|
Protein Conformation | 1 | 2008 | 1271 | 0.020 |
Why?
|
Prognosis | 1 | 2003 | 22220 | 0.020 |
Why?
|
Staurosporine | 1 | 2005 | 144 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2012 | 1258 | 0.020 |
Why?
|
Logistic Models | 1 | 2012 | 3510 | 0.020 |
Why?
|
Curriculum | 1 | 2011 | 901 | 0.020 |
Why?
|
Antigens, CD | 1 | 2010 | 1410 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2009 | 1057 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2012 | 1850 | 0.020 |
Why?
|
CDC2 Protein Kinase | 1 | 2005 | 180 | 0.020 |
Why?
|
Checkpoint Kinase 1 | 1 | 2005 | 179 | 0.020 |
Why?
|
Down-Regulation | 1 | 2010 | 2110 | 0.020 |
Why?
|
Cell Line | 1 | 2012 | 5127 | 0.010 |
Why?
|
Practice Patterns, Physicians' | 1 | 2013 | 1349 | 0.010 |
Why?
|
Leukemia | 1 | 2012 | 1655 | 0.010 |
Why?
|
Cognition | 1 | 2010 | 989 | 0.010 |
Why?
|
Drug Interactions | 1 | 2005 | 573 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 2478 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 3664 | 0.010 |
Why?
|
NF-kappa B | 1 | 2010 | 1584 | 0.010 |
Why?
|
Mitosis | 1 | 2005 | 624 | 0.010 |
Why?
|
Base Sequence | 1 | 2009 | 4927 | 0.010 |
Why?
|
Protein Kinases | 1 | 2005 | 887 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2013 | 3955 | 0.010 |
Why?
|
Kidney | 1 | 2009 | 2196 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 5794 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6269 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 3095 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 6222 | 0.010 |
Why?
|
Internship and Residency | 1 | 2011 | 1469 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2010 | 4163 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2010 | 7140 | 0.010 |
Why?
|
Survival Analysis | 1 | 2010 | 9333 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2005 | 1977 | 0.010 |
Why?
|
DNA Damage | 1 | 2005 | 1986 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 4444 | 0.010 |
Why?
|
Apoptosis | 1 | 2005 | 7754 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 14836 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2005 | 7069 | 0.000 |
Why?
|